Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
King's Daughters Health System is a U.S. regional, not-for-profit health system centered in Ashland, Kentucky, providing hospital-based and outpatient healthcare services across northeastern Kentucky and southern Ohio. Its flagship hospital is UK King's Daughters Medical Center, a 455-bed facility offering intensive, intermediate, and acute care across cardiovascular, orthopedics, oncology, digestive health, stroke and neurology, maternity, and neonatal services. The organization operates a broad network of primary care, specialty care, imaging, and outpatient sites rather than a traditional drug-development pipeline. King's Daughters became part of the University of Kentucky in December 2022 and now operates as UK King's Daughters while remaining locally managed. The system also supports graduate medical education and community health programs in the tri-state region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on King's Daughters Health System.